Dopamine Transporter PET Imaging in Patients with Progressive Supranuclear Palsy and Parkinson's Disease

Ling LI,Ping WU,Jian-jun WU,Jing-jie GE,Yi-hui GUAN,Jian WANG,Cheng-feng JIANG,Chuan-tao ZUO

DOI: https://doi.org/10.3969/j.issn.1008-0678.2018.03.004

2018-01-01

Abstract:Aim To investigate the distribution of striatal dopamine transporter in patients with Parkinson's disease (PD) and progressive supranuclear palsy (PSP) by 11C-CFT PET imaging, and to evaluate its value in the differential diagnosis of PD and PSP. Methods The clinical and 11C-CFT PET imaging data of 40 patients with PD and 20 age- and course-matched patients with PSP were retrospectively analyzed, and another 20 age-matched healthy volunteers were selected as the control group. The 11C-CFT uptake values of the three groups in caudate nucleus ?, anterior putamen (AP) and posterior putamen (PP) were calculated by region of interest (ROI) approach. Results PSP patients showed a faster disease progression and higher UPDRS score and Hochn-Yahr stage when compared with PD patients (P<0.01). The 11C-CFT uptake of PD and PSP groups in caudate, anterior and posterior putamen were significantly lower than that in normal control group (P<0.01). The 11C-CFT uptake of PSP group in each subregion was significantly lower than that in PD group (P<0.001). And the ratio of DAT binding in anterior putamen to caudate (AP/C), posterior putamen to caudate (PP/C) and anterior putamen to posterior putamen was relatively higher in PSP patients than in PD patients (P<0.05). The sensitivity of differential diagnosis of PD and PSP was 85% and specificity was 97.5% when using 1.20 as the cut-off value of the AP/C ratio, and the sensitivity and specificity of differentiating PD from PSP were 90% and 95% respectively, when using 0.77 as the cut-off value of the PP/C ratio. Conclusion 11C-CFT PET imaging can visualize the presynaptic dysfunction of dopaminergic neurons in PD and PSP patients, and the intersubregional ratios can effectively discriminate the two diseases.